1. Home
  2. NRP vs VOR Comparison

NRP vs VOR Comparison

Compare NRP & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Resource Partners LP Limited Partnership

NRP

Natural Resource Partners LP Limited Partnership

N/A

Current Price

$112.99

Market Cap

1.4B

Sector

Energy

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$24.72

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRP
VOR
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
NRP
VOR
Price
$112.99
$24.72
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$45.33
AVG Volume (30 Days)
40.5K
716.6K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
2.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$216,119,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.28
N/A
Revenue Growth
54.66
N/A
52 Week Low
$95.51
$1.90
52 Week High
$128.60
$49.95

Technical Indicators

Market Signals
Indicator
NRP
VOR
Relative Strength Index (RSI) 71.21 64.34
Support Level $100.79 $21.83
Resistance Level $119.80 N/A
Average True Range (ATR) 2.26 1.00
MACD 0.54 -0.15
Stochastic Oscillator 76.64 95.97

Price Performance

Historical Comparison
NRP
VOR

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. The majority of the revenue is generated from the Mineral Rights segment. Geographically, the company's business activity of the group functions through the United States.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: